Ritonavir (Norvir)
Sanal Hastane||1 dk okuma

Klinik kullanımı
HIV Enfeksiyonunun tedavisinde kullanılan anti-retroviral bir ilaçtır. Bir proteaz inhibitörüdür.
Referans değerler
Pik konsantrasyonu (dozdan 2 saat sonra ):8-14 μg/ml
İdame konsantrasyonu (sonraki b.i.d. dozundan önce):1-6 μg/ml
Kaynaklar ve Referanslar
- [1]“Ritonavir (Norvir).”. Treatment review. 1996. PMID: 11363397. PubMed →
- [2]Amariles P, Rivera-Cadavid M, Ceballos M. “Clinical Relevance of Drug Interactions in People Living with Human Immunodeficiency Virus on Antiretroviral Therapy-Update 2022: Systematic Review.”. Pharmaceutics. 2023. PMID: 37896248. PubMed →
- [3]Lea AP, Faulds D. “Ritonavir.”. Drugs. 1996. PMID: 8891466. PubMed →
- [4]Loos NHC, Beijnen JH, Schinkel AH. “The inhibitory and inducing effects of ritonavir on hepatic and intestinal CYP3A and other drug-handling proteins.”. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie. 2023. PMID: 37004323. PubMed →
- [5]“Ritonavir (Norvir).”. Research initiative, treatment action : RITA. 2000. PMID: 11708183. PubMed →
- [6]Marin RC, Behl T, Negrut N, Bungau S. “Management of Antiretroviral Therapy with Boosted Protease Inhibitors-Darunavir/Ritonavir or Darunavir/Cobicistat.”. Biomedicines. 2021. PMID: 33803812. PubMed →


